Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 8 of 8 entries
View as:

Irinotecan Liposomes Combined with Temozolomide and Vincristine in the Treatment of Pediatric Patients with Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06710821 Org: User:
Start: 12/01/24 End: 12/31/26 Due: 12/31/27

Risk Stratification Oriented Treatment of Pediatric Ewing Sarcoma: a Prospective Multicenter Cohort Study

Phase: N/A Priority: Normal
NCT ID: NCT06451302 Org: User:
Start: 04/17/24 End: 12/31/27 Due: 12/31/28

Phase I Clinical Trial of Anlotinib in Progressive, Recurrent, and Refractory Sarcoma in Children

Phase: N/A Priority: Normal
NCT ID: NCT04659733 Org: User:
Start: 12/30/20 End: 12/30/22 Due: 12/30/23

Clinical Trial of VIM With VIT in Children With Relapsed and Refractory Soft Tissue Sarcoma.

Phase: N/A Priority: Normal
NCT ID: NCT06514313 Org: User:
Start: 07/03/24 End: 12/01/26 Due: 12/01/27

Tucidinostat Plus Etoposide in the Treatment of Neuroblastoma in Childhood.

Phase: N/A Priority: Normal
NCT ID: NCT05338541 Org: User:
Start: 05/27/22 End: 12/31/24 Due: 12/31/25

Clinical Value of Next Generation Sequencing in Chinese Childhood Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05076071 Org: User:
Start: 08/06/21 End: 08/06/23 Due: 08/06/24

A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors.

Phase: N/A Priority: Normal
NCT ID: NCT06836492 Org: User:
Start: 01/30/17 End: 12/31/29 Due: 12/31/30

Ondansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compare in Children

Phase: N/A Priority: Normal
NCT ID: NCT06208917 Org: User:
Start: 07/09/23 End: 01/31/27 Due: 01/31/28